“Role of Tumor-Infiltrating Lymphocytes in Predicting Pathologic Complete Response in HER2-Positive Breast Cancer: An IMRAD-Based Analysis”, J Evid Based Med Res, vol. 1, no. 02, Sep. 2025, doi: 10.66687/jebmr.1.02.2025.22.